Application and value of anxiety and depression scale in patients with functional dyspepsia.


Journal

BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676

Informations de publication

Date de publication:
30 Apr 2024
Historique:
received: 23 03 2023
accepted: 22 04 2024
medline: 1 5 2024
pubmed: 1 5 2024
entrez: 30 4 2024
Statut: epublish

Résumé

Patients with functional dyspepsia (FD) cannot be assessed for their mental health using a suitable and practical measure. The purpose of the study is to investigate the usefulness of several anxiety and depression scales in patients with FD, offering recommendations for clinical identification and therapy. From September 2021 to September 2022, patients were sought and selected. The psychological symptoms were assessed using ten depression or anxiety questionnaires. The receiver operating characteristic (ROC) curve, Spearman analysis, Pearson correlation analysis, and single factor analysis were applied. Prospective analysis was performed on 142 healthy individuals and 113 patients with FD. In the case group, anxiety and depression symptoms were more common than in the control group, and the 10 scales showed strong validity and reliability. HAMD had the strongest connection with the PHQ-9 score on the depression scale (0.83). The score correlation between SAS and HAMA on the anxiety analysis scale was the greatest at 0.77. The PHQ-9, SAS, HAMD, and HAMA measures performed exceptionally well in detecting FD with anxiety or depression symptoms (AUC = 0.72, 0.70, 0.70, 0.77, and 0.77, respectively). PHQ-9, SAS, HAMD, and HAMA scales have good application performance in FD patients. They can assist gastroenterologists in evaluating anxiety and depression symptoms, and provide reference and guidance for subsequent treatment.

Sections du résumé

BACKGROUND BACKGROUND
Patients with functional dyspepsia (FD) cannot be assessed for their mental health using a suitable and practical measure. The purpose of the study is to investigate the usefulness of several anxiety and depression scales in patients with FD, offering recommendations for clinical identification and therapy.
METHODS METHODS
From September 2021 to September 2022, patients were sought and selected. The psychological symptoms were assessed using ten depression or anxiety questionnaires. The receiver operating characteristic (ROC) curve, Spearman analysis, Pearson correlation analysis, and single factor analysis were applied.
RESULTS RESULTS
Prospective analysis was performed on 142 healthy individuals and 113 patients with FD. In the case group, anxiety and depression symptoms were more common than in the control group, and the 10 scales showed strong validity and reliability. HAMD had the strongest connection with the PHQ-9 score on the depression scale (0.83). The score correlation between SAS and HAMA on the anxiety analysis scale was the greatest at 0.77. The PHQ-9, SAS, HAMD, and HAMA measures performed exceptionally well in detecting FD with anxiety or depression symptoms (AUC = 0.72, 0.70, 0.70, 0.77, and 0.77, respectively).
CONCLUSIONS CONCLUSIONS
PHQ-9, SAS, HAMD, and HAMA scales have good application performance in FD patients. They can assist gastroenterologists in evaluating anxiety and depression symptoms, and provide reference and guidance for subsequent treatment.

Identifiants

pubmed: 38689345
doi: 10.1186/s40359-024-01744-3
pii: 10.1186/s40359-024-01744-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

244

Informations de copyright

© 2024. The Author(s).

Références

Chuah KH, Cheong SY, Lim SZ, Mahadeva S. Functional dyspepsia leads to more healthcare utilization in secondary care compared with other functional gastrointestinal disorders. J Dig Dis. 2022;23(2):111–7.
doi: 10.1111/1751-2980.13082 pubmed: 35050547
Hantoro IF, Syam AF, Mudjaddid E, Setiati S, Abdullah M. Factors associated with health-related quality of life in patients with functional dyspepsia. Health Qual Life Outcomes. 2018;16(1):83.
doi: 10.1186/s12955-018-0913-z pubmed: 29720190 pmcid: 5930843
Lee K, Kwon CI, Yeniova A, Koyanagi A, Jacob L, Smith L, et al. Global prevalence of functional dyspepsia according to Rome criteria, 1990–2020: a systematic review and meta-analysis. Sci Rep. 2024;14(1):4172.
doi: 10.1038/s41598-024-54716-3 pubmed: 38378941 pmcid: 10879214
Lacy BE, Weiser KT, Kennedy AT, Crowell MD, Talley NJ. Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther. 2013;38(2):170–7.
doi: 10.1111/apt.12355 pubmed: 23725230
Enck P, Azpiroz F, Boeckxstaens G, Elsenbruch S, Feinle-Bisset C, Holtmann G, et al. Functional dyspepsia. Nat Rev Dis Primers. 2017;3:17081.
doi: 10.1038/nrdp.2017.81 pubmed: 29099093
Basnayake C, Kamm MA, Stanley A, Wilson-O’Brien A, Burrell K, Lees-Trinca I et al. Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial. Clin Gastroenterol Hepatol. 2022;20(9):2102-11 e9.
Lacy BE, Everhart K, Crowell MD. Functional dyspepsia: clinical symptoms, psychological findings, and GCSI scores. Dig Dis Sci. 2019;64(5):1281–7.
doi: 10.1007/s10620-018-5347-2 pubmed: 30382539
Jiang SM, Jia L, Lei XG, Xu M, Wang SB, Liu J, et al. Incidence and psychological-behavioral characteristics of refractory functional dyspepsia: a large, multi-center, prospective investigation from China. World J Gastroenterol. 2015;21(6):1932–7.
doi: 10.3748/wjg.v21.i6.1932 pubmed: 25684962 pmcid: 4323473
Singh P, Ballou S, Rangan V, Katon J, Hassan R, Iturrino J, et al. Clinical and psychological factors predict outcome in patients with functional dyspepsia: a prospective study. Clin Gastroenterol Hepatol. 2022;20(6):1251–e81.
doi: 10.1016/j.cgh.2021.07.043 pubmed: 34339874
Jones MP, Tack J, Van Oudenhove L, Walker MM, Holtmann G, Koloski NA, et al. Mood and anxiety disorders Precede Development of Functional Gastrointestinal disorders in patients but not in the Population. Clin Gastroenterol Hepatol. 2017;15(7):1014–20. e4.
doi: 10.1016/j.cgh.2016.12.032 pubmed: 28087404
Thompson E. Hamilton Rating Scale for Anxiety (HAM-A). Occup Med (Lond). 2015;65(7):601.
doi: 10.1093/occmed/kqv054 pubmed: 26370845
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62.
doi: 10.1136/jnnp.23.1.56 pubmed: 14399272 pmcid: 495331
Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371–9.
doi: 10.1016/S0033-3182(71)71479-0 pubmed: 5172928
Zung WW, A SELF-RATING DEPRESSION. SCALE Arch Gen Psychiatry. 1965;12:63–70.
doi: 10.1001/archpsyc.1965.01720310065008 pubmed: 14221692
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
doi: 10.1046/j.1525-1497.2001.016009606.x pubmed: 11556941 pmcid: 1495268
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.
doi: 10.1001/archinte.166.10.1092 pubmed: 16717171
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.
doi: 10.1111/j.1600-0447.1983.tb09716.x pubmed: 6880820
Van Oudenhove L, Aziz Q. The role of psychosocial factors and psychiatric disorders in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10(3):158–67.
doi: 10.1038/nrgastro.2013.10 pubmed: 23358396
Yan L, Zhang X, Li Y, Liu C, Yang H, Yang C. The role of psychological factors in functional gastrointestinal disorders: a systematic review and meta-analysis. Int J Colorectal Dis. 2023;38(1):65.
doi: 10.1007/s00384-023-04333-9 pubmed: 36894717
Wuestenberghs F, Juge M, Melchior C, Desprez C, Leroi AM, Gourcerol G. Association between Symptoms, Quality of Life, and gastric emptying in dyspeptic patients. J Neurogastroenterol Motil. 2019;25(4):534–43.
doi: 10.5056/jnm19060 pubmed: 31587545 pmcid: 6786450
Sperber AD, Freud T, Aziz I, Palsson OS, Drossman DA, Dumitrascu DL, et al. Greater Overlap of Rome IV disorders of gut-brain interactions leads to increased disease severity and poorer quality of life. Clin Gastroenterol Hepatol. 2022;20(5):e945–56.
doi: 10.1016/j.cgh.2021.05.042 pubmed: 34052391
Teh KK, Ng YK, Doshi K, Tay SW, Hao Y, Ang LY, et al. Mindfulness-based cognitive therapy in functional dyspepsia: a pilot randomized trial. J Gastroenterol Hepatol. 2021;36(8):2058–66.
doi: 10.1111/jgh.15389 pubmed: 33373492
Liu J, Jia L, Lei XG, Jiang SM, Wang SB, Xu M. The clinical-psychological features of functional dyspepsia patients with weight loss: a multi-center study from China. Digestion. 2015;91(3):197–201.
doi: 10.1159/000375400 pubmed: 25790833
Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. Lancet. 2020;396(10263):1689–702.
doi: 10.1016/S0140-6736(20)30469-4 pubmed: 33049222
Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–e1143.
doi: 10.1053/j.gastro.2020.04.014 pubmed: 32294476
Godeau D, Petit A, Richard I, Roquelaure Y, Descatha A. Return-to-work, disabilities and occupational health in the age of COVID-19. Scand J Work Environ Health. 2021;47(5):408–9.
doi: 10.5271/sjweh.3960 pubmed: 34003294 pmcid: 8259700
Black CJ, Houghton LA, Ford AC. Insights into the evaluation and management of dyspepsia: recent developments and new guidelines. Th Adv Gastroenterol. 2018;11:1756284818805597.
Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. Lancet. 2020;396(10263):1664–74.
doi: 10.1016/S0140-6736(20)32115-2 pubmed: 33049221
Koloski N, Holtmann G, Talley NJ. Is there a causal link between psychological disorders and functional gastrointestinal disorders? Expert Rev Gastroenterol Hepatol. 2020;14(11):1047–59.
doi: 10.1080/17474124.2020.1801414 pubmed: 32715790
Wauters L, Ceulemans M, Vanuytsel T. Duodenum at a crossroads: key integrator of overlapping and psychological symptoms in functional dyspepsia? Neurogastroenterol Motil. 2021;33(10):e14262.
doi: 10.1111/nmo.14262 pubmed: 34561921
Agawa S, Futagami S, Yamawaki H, Gudis K, Higuchi K, Kaneko K, et al. State of anxiety may be associated with exocrine pancreatic insufficiency in functional dyspepsia patients with pancreatic enzyme abnormalities. J Clin Biochem Nutr. 2022;70(2):175–81.
doi: 10.3164/jcbn.21-67 pubmed: 35400815

Auteurs

Yejiao Ruan (Y)

The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, 1111 East Wenzhou Dadao, Longwan District, Wenzhou, 325000, Zhejiang, China.

Hao Lin (H)

The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, 1111 East Wenzhou Dadao, Longwan District, Wenzhou, 325000, Zhejiang, China.

Xinru Lu (X)

The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, 1111 East Wenzhou Dadao, Longwan District, Wenzhou, 325000, Zhejiang, China.

Yiying Lin (Y)

The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, 1111 East Wenzhou Dadao, Longwan District, Wenzhou, 325000, Zhejiang, China.

Jian Sun (J)

The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, 1111 East Wenzhou Dadao, Longwan District, Wenzhou, 325000, Zhejiang, China.

Cengqi Xu (C)

The Second Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Lingjun Zhou (L)

The Second Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Zhenzhai Cai (Z)

The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, 1111 East Wenzhou Dadao, Longwan District, Wenzhou, 325000, Zhejiang, China. caizhenzhai@wmu.edu.cn.

Xiaoyan Chen (X)

The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, 1111 East Wenzhou Dadao, Longwan District, Wenzhou, 325000, Zhejiang, China. cxy_dr@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH